How many stocks are there of Progyny?
The current number of stocks of Progyny is 100.67 M undefined.
Progyny Stocks 2024
Progyny Stocks
100.67 M
Ticker
PGNY
ISIN
US74340E1038
WKN
A2PT5Q
In 2024, Progyny had 100.67 M outstanding stocks, a 0% change from the 100.67 M stocks in the previous year.
The Progyny Stocks history
| YEAR | NUMBER OF STOCKS (undefined USD) |
|---|---|
| 2029e | 100.67 |
| 2028e | 100.67 |
| 2027e | 100.67 |
| 2026e | 100.67 |
| 2025e | 100.67 |
| 2024e | 100.67 |
| 2023 | 100.67 |
| 2022 | 100 |
| 2021 | 100.4 |
| 2020 | 99.1 |
| 2019 | 82.2 |
| 2018 | 82.2 |
| 2017 | 82.2 |
Progyny shares outstanding US74340E1038 · A2PT5Q
The number of shares was Progyny in 2023 — This indicates how many shares 100.672 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Progyny earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Progyny's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Progyny’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Progyny's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2017 | 82.2 M Aktien |
| 2018 | 82.2 M Aktien |
| 2019 | 82.2 M Aktien |
| 2020 | 99.1 M Aktien |
| 2021 | 100.4 M Aktien |
| 2022 | 100 M Aktien |
| 2023 | 100.67 M Aktien |
| 2024e | 100.67 M Aktien |
| 2025e | 100.67 M Aktien |
| 2026e | 100.67 M Aktien |
| 2027e | 100.67 M Aktien |
| 2028e | 100.67 M Aktien |
| 2029e | 100.67 M Aktien |
Progyny Aktienanalyse
What does Progyny do?
Progyny Inc. is a company specializing in reproductive medicine and fertility treatments. It was founded in New York City in 2008 and has been listed on the NASDAQ stock exchange since 2019. The idea for Progyny arose when founder Gina Bartasi herself had difficulty getting pregnant and was searching for support and transparent information. She recognized the need to offer a better and more accessible service for people with fertility problems, thus founding Progyny. Progyny's business model is to offer employers a fertility benefit to help their employees, especially women, with family planning. It provides customized fertility treatments and financial assistance through its innovative programs. This allows employers to position themselves as progressive and inclusive while also increasing the bond and well-being of their employees. The different divisions of Progyny include fertility management, fertility measurement and monitoring, and fertility benefits. The fertility management solutions provide companies with comprehensive care for their employees, including counseling and support on fertility and family planning. They also provide access to an exclusive network practice specializing in reproductive medicine, including in vitro fertilization (IVF) and egg donation. The fertility measurement and monitoring program offers a personalized fertility profile that allows employees to track their fertility status to maximize their chances of a successful pregnancy. Progyny utilizes advanced methods of artificial intelligence and machine learning for this purpose. Progyny's fertility benefits include financial support for fertility treatments and medications that are not normally covered by health insurance. Additionally, the company offers a unique membership option that provides unlimited access to master fertility practices for one year. Progyny also offers a comprehensive patient experience through world-leading doctors and a patented technology platform. The platform provides support in navigating the fertility process and ensures that patients receive the best possible medical and financial care. Overall, Progyny has a significant impact on the field of reproductive medicine. With an innovative solution tailored to the needs of employers and strong support for aspiring parents, the company achieves a higher success rate in pregnancy compared to traditional fertility treatments. Progyny's technology platform improves workflow efficiency and communication in the practice, leading to a better patient experience and greater engagement. Overall, Progyny offers a holistic solution for employers and employees tailored to the unique challenges of family planning and fertility. With innovative approaches and a focus on the well-being of female employees, the company has taken a unique position in the market and is expected to continue to play a strong role in the industry. Progyny ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Progyny's Shares Outstanding
Progyny's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Progyny’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Progyny’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Progyny’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Progyny stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Progyny are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Progyny evolved in recent years?
The number of shares of Progyny has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Progyny as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Progyny?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Progyny pay?
Over the past 12 months, Progyny paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Progyny is expected to pay a dividend of 0 USD.
What is the dividend yield of Progyny?
The current dividend yield of Progyny is .
When does Progyny pay dividends?
Progyny pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Progyny?
Progyny paid dividends every year for the past 0 years.
What is the dividend of Progyny?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Progyny located?
Progyny is assigned to the 'Health' sector.
Wann musste ich die Aktien von Progyny kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Progyny from 12/18/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/18/2024.
When did Progyny pay the last dividend?
The last dividend was paid out on 12/18/2024.
What was the dividend of Progyny in the year 2023?
In the year 2023, Progyny distributed 0 USD as dividends.
In which currency does Progyny pay out the dividend?
The dividends of Progyny are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Progyny
Our stock analysis for Progyny Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Progyny Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
